[Selective calcineurin inhibitor. Neurodermatitis patients need fewer corticoids].
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D065095:Calcineurin Inhibitors; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D009450:Neurodermatitis / Q000188:drug therapy*; D016559:Tacrolimus / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D065095:Calcineurin Inhibitors; C117268:pimecrolimus; D016559:Tacrolimus